Fermentative Production of Biobased Acetone

Introduction

Acetone is a key industrial solvent used in plastics, paints, pharmaceuticals, and cosmetics, traditionally derived from petroleum-based processes like cumene oxidation. However, rising interest in biobased chemicals has revived research into its microbial production via fermentation, a method first used during WWI.

The fermentative production of biobased acetone employs engineered microbes—typically Clostridium species or genetically modified E. coli and Saccharomyces cerevisiae—to convert sugars or biomass-derived feedstocks into acetone, often alongside butanol and ethanol (ABE fermentation). Recent advances in metabolic engineering have enhanced yields, selectivity, and economic viability, making biobased acetone a competitive green alternative.

What Products Are Produced?

• Acetone – Green solvent, plastics precursor, intermediate for isopropanol
• Butanol and Ethanol – Co-products in ABE fermentation
• Isopropanol (via downstream reduction) – Disinfectant and fuel blendstock
• Biogas or biosolids – From waste biomass fermentation

Pathways and Production Methods

1. Classical ABE Fermentation (Acetone–Butanol–Ethanol)

• Uses Clostridium acetobutylicum or C. beijerinckii
• Substrates: glucose, starch, lignocellulosic hydrolysates
• Acetone produced via:
• Pyruvate → Acetoacetate → Acetone (via acetoacetate decarboxylase)

2. Metabolically Engineered Pathways

• E. coli engineered with acetoacetate and acetone synthesis genes
• Redirecting carbon flux from glycolysis and TCA intermediates
• Cofactor balancing and dynamic regulation for acetone overproduction

3. Co-Fermentation and Consolidated Bioprocessing

• Use of C5 and C6 sugars from lignocellulosic biomass
• Integration with enzyme secretion for direct biomass-to-acetone conversion

Catalysts and Key Tools Used

• Key Enzymes:
• Acetoacetate decarboxylase (adc) – Acetoacetate → Acetone
• Thiolase (thl) – Acetyl-CoA → Acetoacetyl-CoA
• CoA transferase (ctfAB) – CoA recycling and pathway flux
• Host Microorganisms:
• Clostridium acetobutylicum, C. saccharoperbutylacetonicum – Natural producers
• Engineered E. coli, S. cerevisiae – Improved stability and productivity
• Thermophilic microbes – For lignocellulosic substrates and consolidated bioprocessing
• Fermentation Systems:
• Anaerobic stirred tank reactors
• Immobilized cell systems for reuse
• Gas stripping or solvent extraction for acetone recovery

Case Study: Green Acetone Production by Greenyug + ADM (USA)

Highlights

• Greenyug developed a renewable acetone process using engineered microbial pathways
• Partnered with ADM to build a commercial biobased acetone plant in Illinois
• Feedstock: corn dextrose, product: high-purity acetone for cosmetic and pharma sectors
• Reduced carbon footprint by ~70% compared to fossil-derived acetone

Timeline

• 2014 – Lab-scale pathway design and strain development
• 2017 – Process scaled to pilot scale
• 2020 – Construction of commercial plant commenced
• 2022 – First shipments of biobased acetone delivered to global customers

Global and Indian Startups Working in This Area

Global

• Greenyug (USA) – Renewable acetone via fermentation
• Celtic Renewables (UK) – ABE fermentation revival using whisky waste
• Butamax (USA) – Producing isopropanol and butanol with potential acetone routes
• Terravia (USA) – Algal-based solvent production under investigation

India

• Praan Biosciences (Pune) – Early-stage work on fermentation-based solvent pathways
• CSIR-IICT, CSIR-NCL – Developing microbial acetone from agro-wastes
• IIT Delhi, ICT Mumbai – Ongoing projects on microbial strain optimization
• Public-private ventures under BIRAC – Supporting green solvent innovation

Market and Demand

The global acetone market was valued at USD 5.8 billion in 2023, with growing demand in Asia-Pacific. Biobased acetone is projected to grow at a CAGR of ~6.9%, particularly for green cosmetics, coatings, electronics, and bio-based packaging.

Major End-Use Segments:

• Pharmaceuticals and personal care (solvent in formulations)
• Paints and coatings (resin and pigment carrier)
• Plastics and composites (precursor for bisphenol-A and polycarbonate)
• Laboratory and industrial solvents
• Fuel blending and isopropanol production

Key Growth Drivers

• Demand for low-carbon solvents in pharma and consumer goods
• Regulatory pressure to phase out fossil-derived VOCs
• Availability of agro-waste and biomass feedstocks
• Revival of ABE fermentation with modern tools
• Incentives for bio-based chemicals under circular economy goals

Challenges to Address

• Product inhibition due to acetone toxicity to microbes
• Volatility and recovery cost of acetone from broth
• Need for strain robustness and higher yields
• Economic competition with petrochemical acetone
• Limited scale-up experience for modern bioacetone routes

Progress Indicators

• 1916 – Acetone produced at industrial scale using Clostridium in WWI
• 2010 – Metabolic engineering renews interest in microbial acetone
• 2016 – Commercial partnerships for green acetone initiated
• 2021 – EU and US include acetone in biobased chemical funding programs
• 2023 – India explores bioacetone as a green solvent option in pharma

Fermentative acetone production is at TRL 8–9 in the USA and UK, with commercial-scale systems operational, and at TRL 4–6 in India, with lab and pilot-level R&D ongoing.

Conclusion

The fermentative production of biobased acetone is a clear example of how century-old microbial processes can be revitalized with modern biotechnology to meet 21st-century sustainability goals. As industries pivot toward green solvents and climate-friendly chemicals, microbial acetone stands out for its simplicity, scalability, and circularity.

With the right policy push and feedstock integration, India can accelerate its transition to biobased solvent manufacturing, building a resilient, low-carbon chemical economy.

Wish to have bio-innovations industry or market research support from specialists for climate & environment? Talk to BioBiz team – Call Muthu at +91-9952910083 or send a note to ask@biobiz.in